HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Expression of insulin-like growth factor-II and its receptor in pediatric and adult adrenocortical tumors.

AbstractBACKGROUND:
Adrenocortical tumors are heterogeneous neoplasms with incompletely understood pathogenesis. IGF-II overexpression has been consistently demonstrated in adult adrenocortical carcinomas.
OBJECTIVES:
The objective of the study was to analyze expression of IGF-II and its receptor (IGF-IR) in pediatric and adult adrenocortical tumors and the effects of a selective IGF-IR kinase inhibitor (NVP-AEW541) on adrenocortical tumor cells.
PATIENTS:
Fifty-seven adrenocortical tumors (37 adenomas and 20 carcinomas) from 23 children and 34 adults were studied.
METHODS:
Gene expression was determined by quantitative real-time PCR. Cell proliferation and apoptosis were analyzed in NCI H295 cells and a new cell line established from a pediatric adrenocortical adenoma.
RESULTS:
IGF-II transcripts were overexpressed in both pediatric adrenocortical carcinomas and adenomas. Otherwise, IGF-II was mainly overexpressed in adult adrenocortical carcinomas (270.5 +/- 130.2 vs. 16.1 +/- 13.3; P = 0.0001). IGF-IR expression was significantly higher in pediatric adrenocortical carcinomas than adenomas (9.1 +/- 3.1 vs. 2.6 +/- 0.3; P = 0.0001), whereas its expression was similar in adult adrenocortical carcinomas and adenomas. IGF-IR expression was a predictor of metastases in pediatric adrenocortical tumors in univariate analysis (hazard ratio 1.84; 95% confidence interval 1.28-2.66; P = 0.01). Furthermore, NVP-AEW541 blocked cell proliferation in a dose- and time-dependent manner in both cell lines through a significant increase of apoptosis.
CONCLUSION:
IGF-IR overexpression was a biomarker of pediatric adrenocortical carcinomas. Additionally, a selective IGF-IR kinase inhibitor had antitumor effects in adult and pediatric adrenocortical tumor cell lines, suggesting that IGF-IR inhibitors represent a promising therapy for human adrenocortical carcinoma.
AuthorsMadson Q Almeida, Maria Candida Barisson Villares Fragoso, Claudimara Ferini Pacicco Lotfi, Mariza Gerdulo Santos, Mirian Yumie Nishi, Marcia Helena Soares Costa, Antonio Marcondes Lerario, Carolina Canton Maciel, Gabriele Ebling Mattos, Alexander Augusto Lima Jorge, Berenice B Mendonca, Ana Claudia Latronico
JournalThe Journal of clinical endocrinology and metabolism (J Clin Endocrinol Metab) Vol. 93 Issue 9 Pg. 3524-31 (Sep 2008) ISSN: 0021-972X [Print] United States
PMID18611974 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Receptor, IGF Type 2
  • Insulin-Like Growth Factor II
Topics
  • Adenoma (genetics, pathology)
  • Adolescent
  • Adrenal Cortex Neoplasms (genetics, pathology)
  • Adult
  • Aged
  • Carcinoma (genetics, pathology)
  • Child
  • Child, Preschool
  • Female
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Infant
  • Insulin-Like Growth Factor II (genetics, metabolism)
  • Male
  • Middle Aged
  • Neoplasm Metastasis
  • Receptor, IGF Type 2 (genetics, metabolism)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: